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Abstract Article Info 
Introduction: Combination of chemotherapy and radiation are the treatment of choice in advance stage of 
nasopharyngeal carcinoma. Cisplatin-based chemotherapy is a regiment of choice in those cases. Several studies 
show that cisplatin-based chemotherapy affect renal function. 
Objective: To evaluate and compare the renal function before and after chemotherapy through comparing the 
blood urea nitrogen and creatinine serum level in patients with nasopharyngeal cancer who receive cisplatin and 
paclitaxel chemotherapy.  
Method: Using Medical records data for study design. Design of this study is before and after using medical 
records data in West Nusa Tenggara General Hospital in Lombok. 
Result: There were 33 patients who fulfill the inclusion and exclusion criteria in this study. Most of the patients 
are male with male and female ratio 3:1. The youngest patient age is eight years old, on the other hand, the 
oldest is 70 years old with the average age 46.6 years old. According to histopathology finding, on this study 
researcher didn't found WHO type I and most the patients were WHO type III (89.9 %). The mean blood urea 
nitrogen concentration before chemotherapy is 25.00 and after the treatment 33.33 with the p-value 0.01 with 
the paired t-test. On the other hand, creatinine serum level before and after chemotherapy consecutively 0.99 
and 1.10. P value 0.15, or there is no significant difference. 
Conclusion: Blood urea nitrogen and creatinine serum are increase after cisplatin-based chemotherapy. 
However, only BUN has a significant difference. 
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1. INTRODUCTION 
Lombok is one of the beautiful islands in Indonesia. It lies in the middle 
part of Indonesia and surrounded by a beautiful beach. Because of its 
location, most of their citizen consume the fish and its products such as 
salted fish and fermented shrimpfish. Salted fish and other corned food are 
recognized as one of the risk factors for the development of nasopharyngeal 
carcinoma [1]. Salted fish consumption recognized as a 3rd most risk factors 
on nasopharyngeal carcinoma [2]. 
Similar to other regions in Indonesia, the cases of nasopharyngeal 
carcinoma are relatively high. The research in Lombok in 2015 found that 
48 patients with undifferentiated squamous cell carcinoma [3]. In advanced, 
the Incidence of nasopharyngeal carcinoma in Indonesia is predicted about 
5.6/100.000 people or there will be 15.000 cases annually [4]. According to 
global cancer statistic (GLOBOCAN) 2018, there are 129.079 new cases 
worldwide or 0.7% of all cancer cases with 72.987 death due to 
nasopharyngeal carcinoma annually [5]. 
The more, unfortunately, the cases usually found in the advanced stage. 
This lead to the need for chemotherapy on its treatment. According to 
NCCN, advance nasopharyngeal carcinoma should be treated with a 
combination of radiotherapy and chemotherapy. Chemotherapy could be 
given in the scheme of adjuvant, neoadjuvant, concurrent or concomitantly [6]. 
Chemotherapy of choice in nasopharyngeal carcinoma is using the 
platinum-based. On the other hand, due to this medicine containing heavy 
metal, this substance may affect several organs, including renal function. 
Estimated 20% of patient who receives cisplatin have a renal dysfunction 
and 33% of them experience an acute kidney injury [7].  Arunkumar et al. 
(2012) found there was a significant difference of serum creatinine between 
before and post-chemotherapy with cisplatin in a patient with squamous cell 
carcinoma head and neck. The mean concentration of creatinine before and 
post-chemotherapy consecutively (0.730.08 and 1.071.19 with P<0.05). 
On the other hand, the level of blood urea nitrogen (BUN) is decreased 
significantly [8]. Tezcan et al. (2013), found both BUN and creatinine are 
increased significantly after three cycles of cisplatin administration [9]. 
In West Nusa Tenggara hospital, most of the patient with nasopharyngeal 
carcinoma was treated with a combination of cisplatin and paclitaxel, although 
the NCCN recommended a combination of cisplatin 5-FU as first-line treatment. 
This is due to a shorter time of hospitalization and the effectiveness is comparable 
with a combination of cisplatin-5FU [6]. According to those, our team is 
interesting to investigate the BUN and creatinine serum level before and after 
chemotherapy with cisplatin and paclitaxel.  
The aim of this study  are to evaluate and compare the renal function 
before and after chemotherapy through comparing the blood urea nitrogen and 
creatinine serum level in patients with nasopharyngeal carcinoma who receive 
cisplatin and paclitaxel chemotherapy. Besides, this study could be used as a 
references for doing a renal function monitoring for nasopharyngeal 
carcinoma patients treated by chemotherapy. 
2. MATERIAL AND METHODS 
This study is conducted before and after methods, by using 
retrospective data in West Nusa Tenggara General Hospital. The data was 
compiled through the medical record to find out all of the patients with 
nasopharyngeal carcinoma stage III and IV since 2016-2018 who receive 
the platinum-based chemotherapy (cisplatin and paclitaxel). Data which will 
be collected including the age, sex, stage of cancer, histopathology, the 
serum level of blood urea nitrogen and creatinine. The data will arrange and 
analysis with paired t-test to knows a different concentration or level of 
blood urea nitrogen and creatinine before and after chemotherapy. Patients 
with incomplete data will be excluded. 
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3. RESULT 
In this study, there are 33 patients with nasopharyngeal carcinoma who 
fulfilled the inclusion and exclusion criteria. Most of the patients are male with 
male and female ratio 3:1. The youngest patient age is 8 years old, on the other 
hand, the oldest is 70 years old with the average age 46.6 years old. According to 
histopathology finding, on this study researcher didn’t found WHO type I and 
most of the patients were WHO type III (89.9 %). This data is shown in table 1. 
Table 1. Characteristic of patients 
Characteristics Frequency Percentage 
Ages   
Youngest 
Oldest  
Mean 
8 
70 
46.6 
2 
2 
Sex   
Male 
Female 
21 
12 
63.6 
36.4 
Stage   
III 
IV 
20 
13 
60.6 
29.4 
Histopathology   
WHO type I 
WHO Type II 
WHO type III 
0 
3 
30 
0 
9.1 
89.9 
According to the laboratory result, the mean blood urea nitrogen 
concentration before chemotherapy is 25.00 and after the treatment 33.33 with 
the p-value 0.01, the paired t-test result as shown in table 2. On the other hand, 
creatinine serum level before and after chemotherapy consecutively 0.99 and 
1.10. P value >0.05, or there is no significance difference. 
Table 2. The paired t-test for the concentration of Urea and creatinine 
Variable Mean Before Mean After 
Standard 
deviation 
P value 
Blood Urea Nitrogen (BUN) 25.00 33.33 14.66 0.01 
Creatinine 0.99 1.10 0.41 0.15 
4. DISCUSSION 
The general characteristic of the patient in this study is similar to 
another previous study. In our study the male to male ratio is 3:1, the mean 
age is 46.6 years old and 89.9% is WHO type III. Adham et al (2012) found 
the most age between 30-50 years old with the most histopathologic finding 
was WHO type III (85%) [4]. Peng et al (2016) found a male to male ratio 
4:1 and 99.8% with WHO type II and III [10]. 
Several studies showed that platinum-based chemotherapy has an effect 
on renal function [7], [8], [9], [10]. Cisplatin is excreted through the kidney, 
furthermore, its logic that cisplatin may affect the kidney function. Review 
by Miller et al. (2010) who describe the mechanisms of cisplatin 
nephrotoxicity states that injury of the kidney may happen by the 
accumulation of cisplatin on kidney cell, biotransformation of cisplatin in 
kidney, mediated the cytotoxic effect on DNA and apoptotic pathways of 
cisplatin cytotoxicity [11]. According Ozkok et al (2014) on their review, 
states that the general pathophysiology of cisplatin on acute kidney injury 
involves 4 major mechanisms: (1) proximal tubular injury, (2) oxidative 
stress, (3) inflammation, and (4) vascular injury in the kidney [12]. 
In this study, there is an increasing level of blood urea nitrogen and 
creatinine before and after chemotherapy. However, only BUN has a 
significant difference before and after chemotherapy. Although creatinine 
serum level increase after chemotherapy, but its difference is not significant. 
This result indicated the occurrence of kidney injury.  
Latcha et al. (2016) found an increase of mean serum creatinine level from 
0.99 to 1.18 mg/dl after first cisplatin administration and remain in the level of 
1.14 mg/dl a year post-chemotherapy [13]. Arunkumar et al. (2010) found a 
significant serum creatinine level before and after five cycles of cisplatin 
administration (from 0.78 to 1.13 gr/dl), but BUN is not significant although there 
is an increase (from 12.28 to 13.35 gr/dl) [8]. Noviyani et al. (2017) on 
prospective studies found there is no significant difference between BUN and 
creatinine serum in patients with 6 cycles paclitaxel and cisplatin [14].  
Another marker to knows the effect of chemotherapy to renal function is 
glomerulal filtration rate (GFR). Loh et al (2017) on their research on urothelial 
cancer found that Median GFR change was 1.6% for patients with pretreatment 
GFR < 60 mL/min compared to 10.9% for patients with pre- treatment GFR >60 
mL/min (P 1⁄4 .17). They concluded that urothelial cancer patients with GFR < 
60 mL/min do not experience a greater decline in renal function after cisplatin 
compared to patients with GFR > 60 mL/min [15]. 
According to those references, not all studies agree with the renal effect 
of cisplatin-based chemotherapy. Miller (2010) explained several risk 
factors make the increase of cisplatin nephrotoxicity, including dose and 
frequency of administration, cumulative dose, older age, female sex, 
smoking, hypoalbuminemia, and pre-existing renal insufficiency. On the 
other hand, factors such as diabetes and OCT2 polymorphisms have 
decreased the risk of renal dysfunction [11]. Hayati et al (2016) on his mini 
review found the most important risk factors for cisplatin induced 
nephrotoxicity including higher doses of cisplatin, previous cisplatin 
chemotherapy, underlying kidney damage and concurrent treatment with 
other potential nephrotoxin agents, such as aminoglycosides, nonsteroidal 
anti-inflammatory agents, or iodinated contrast media. [16] 
In this study, maybe because of mean age is under 50 years and 
predominantly male, lead to a decrease of nephrotoxicity. The low BUN and 
creatinine in this study are healthy, this is also lead to a lower effect of 
cisplatin-based chemotherapy. However, more detailed research should be 
done to make sure the exact effect of cisplatin-based to the renal function in 
nasopharyngeal carcinoma patients. Future research with larger samples 
could give more accurate and valid result. 
5. CONCLUSION 
Blood urea nitrogen and creatinine serum are increase after cisplatin-
paclitaxel chemotherapy. However, only BUN has a significant difference. 
This result indicated the occurance of kidney injury. 
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